Skip to main content
Premium Trial:

Request an Annual Quote

Chief of Staff Choice

US President-elect Joe Biden has chosen Ronald Klain to serve as his chief of staff, according to the New York Times.

As the Washington Post notes, Klain has long worked in Washington, and served as chief of staff to Biden when he was vice president as well as to Al Gore when he was vice president. Additionally, the Post notes that during the Obama Administration, Klain coordinated the response to the Ebola outbreak as the Ebola Czar and adds that Klain has since been critical of the Trump administration response to the COVID-19 pandemic.

CNN notes that the choice underscores the emphasis Biden is placing on the coronavirus. His experience, NBC News adds, gives Klain "both familiarity with Biden and important credentials as the COVID-19 response will consume Biden's opening months."

Earlier this year, Klain spoke with Wired about what he learned from the Ebola outbreak that could be applicable to the COVID-19 pandemic. "The high-level lessons applicable today are, first and foremost, let the medical experts be the touchstone of the response — let them be the people who are formulating this strategy, let them be the spokespeople," Klain told it.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.